Lumonus, a Sydney, Australia-based company specializing in AI-powered radiation oncology workflow solutions, has raised A$25 million in a Series B funding round.
Investors
The round was led by Aviron Investment Management, with continued participation from Oncology Ventures.
Aviron Investment Management is a private investment firm focused on healthcare and technology, partnering with high-growth companies that use technology to tackle complex challenges in life sciences, sports tech, and health and wellness. Committed to long-term value creation, Aviron provides strategic capital and operational expertise to help scale globally impactful solutions. The firm has supported Lumonus since its inception, guiding its growth and strategic direction.
Lumonus Use of Funds
The company will use the new capital to expand its U.S. go-to-market and clinical success teams, advance its flagship products (Lumonus AI Physician and Lumonus AI Dosimetry), and invest in clinical informatics and real-world evidence initiatives.
About Lumonus
Lumonus AI is a digital oncology platform designed to transform cancer care through an AI-native clinical infrastructure. Built in partnership with leading cancer centers, the Lumonus platform automates and orchestrates critical oncology workflows to improve quality, accelerate delivery, and minimize administrative burden. Lumonus operates across the United States, Australia, and Europe. To date, the Lumonus AI platform has supported clinicians in consulting and prescribing over 280,000 cancer treatments and has automated the creation of over 75,000 cancer treatment plans.
Funding Details
Company: Lumonus Pty Ltd
Raised: A$25.0M
Round: Series B
Funding Date: November 2025
Lead Investor: Aviron Investment Management
Additional Investors: Oncology Ventures
Company Website: https://www.lumonus.com/
Software Category: AI / Radiation Oncology Workflow Solutions
Source: https://www.prnewswire.com/apac/news-releases/lumonus-raises-a25-million-in-series-b-to-scale-ai-powered-oncology-workflows-globally-302607862.html